The MCP/eotaxin subfamily of CC chemokines

Cytokine and Growth Factor Reviews

Volumn 10, Issue 1, 1999, Pages 61-86

  Van Coillie, Els ^a   Van Damme, Jo ^a   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Eotaxin; Monocyte chemotactic proteins; Pathology; Physiology

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CC CHEMOKINE RECEPTOR 3; CHEMOKINE RECEPTOR; CYTOKINE; EOSINOPHIL CHEMOTACTIC FACTOR; EOTAXIN; FRACTALKINE; LYMPHOTACTIN; MONOCYTE CHEMOTACTIC PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL; ATHEROSCLEROSIS; CHROMOSOMAL LOCALIZATION; CONGESTIVE HEART FAILURE; ENDOMETRIOSIS; ENTERITIS; GENE STRUCTURE; GENETICS; HUMAN; INFLAMMATORY DISEASE; LEUKOCYTE MIGRATION; LUNG DISEASE; MOLECULAR GENETICS; MOLECULAR WEIGHT; MULTIGENE FAMILY; MULTIPLE SCLEROSIS; NONHUMAN; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CYTOKINES; HUMANS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; RECEPTORS, CHEMOKINE; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0033103460     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(99)00005-2     Document Type: Review

References (245)

1. Opdenakker G., Fibbe W.E., Van Damme J. The molecular basis of leukocytosis. Immunol Today. 19:1998;182-189.
2. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
3. Opdenakker G., Van Damme J. Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine. 4:1992;251-258.
4. Kennedy J., Kelner G.S., Kleyensteuber S., Schall T.J., Weiss M.C., Yssel H., Schneider P.V., Cocks B.G., Bacon K.B., Zlotnik A. Molecular cloning and functional characterization of human lymphotactin. J Immunol. 155:1995;203-209.
5. 3C motif. Nature. 385:1997;640-644.
6. Pan Y., Lloyd C., Zhou H., Dolich S., Deeds J., Gonzalo J-A., Vath J., Gosselin M., Ma J., Dussault B., Woolf E., Alperin G., Culpepper J., Gutierrez-Ramos J.C., Gearing D. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature. 387:1997;611-617.
7. Modi W.S., Chen Z-Q. Localization of the human CXC chemokine subfamily on the long arm of chromosome 4 using radiation hybrids. Genomics. 47:1998;136-139.
8. Naruse K., Ueno M., Satoh T., Nomiyama H., Tei H., Takeda M., Ledbetter D.H., Van Coillie E., Opdenakker G., Gunge N., Sakaki Y., Iio M., Miura R. A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2. Genomics. 34:1996;236-240.
9. Hieshima K., Imai T., Opdenakker G., Van Damme J., Kusuda J., Tei H., Sakaki Y., Takatsuki K., Miura R., Yoshie O., Nomiyama H. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem. 272:1997;5846-5853.
10. Nomiyama H., Imai T., Kusuda J., Miura R., Callen D.F., Yoshie O. Assignment of the human CC chemokine gene TARC (SCYA17) to chromosome 16q13. Genomics. 40:1997;211-213.
11. Yoshida R., Imai T., Hieshima K., Kusuda J., Baba M., Kitaura M., Nishimura M., Kakizaki M., Nomiyama H., Yoshie O. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem. 272:1997;13803-13809.
12. Nagira M., Imai T., Hieshima K., Kusuda J., Ridanpää M., Takagi S., Nishimura M., Kakizaki M., Nomiyama H., Yoshie O. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J Biol Chem. 272:1997;19518-19524.
13. D'Souza M.P., Harden V.A. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nat Med. 2:1996;1293-1300.
14. Horuk R., Chitnis C.E., Darbonne W.C., Colby T.J., Rybicki A., Hadley T.J., Miller L.H. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science. 261:1993;1182-1184.
15. Forssmann U., Uguccioni M., Loetscher P., Dahinden C.A., Langen H., Thelen M., Baggiolini M. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med. 185:1997;2171-2176.
16. Proost P., Wuyts A., Opdenakker G., Van Damme J. Monocyte chemotactic proteins 1, 2 and 3. Mire-Sluis A., Thorpe R. 'Cytokines', a volume for the handbook of immunopharmacology. 1998;489-506 Academic Press, London UK.
17. Rollins B.J. Chemokines. Blood. 90:1997;909-928.
18. Robinson E.A., Yoshimura T., Leonard E.J., Tanaka S., Griffin P.R., Shabanowitz J., Hunt D.F., Appella E. Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. Proc Natl Acad Sci USA. 86:1989;1850-1854.
19. Van Damme J., Proost P., Lenaerts J.P., Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med. 176:1992;59-65.
20. Garcia-Zepeda E.A., Rothenberg M.E., Ownbey R.T., Celestin J., Leder P., Luster A.D. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med. 2:1996;449-456.
21. Kitaura M., Nakajima T., Imai T., Harada S., Combadiere C., Tiffany H.L., Murphy P.M., Yoshie O. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem. 271:1996;7725-7730.
22. Ponath P.D., Qin S., Ringler D.J., Clark-Lewis I., Wang J., Kassam N., Smith H., Shi X., Gonzalo J-A., Newman W., Gutierrez-Ramos J-C., Mackay C.R. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest. 97:1996;604-612.
23. Uguccioni M., Loetscher P., Forssmann U., Dewald B., Li H., Lima S.H., Li Y., Kreider B., Garotta G., Thelen M., Baggiolini M. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med. 183:1996;2379-2384.
24. Berkhout T.A., Sarau H.M., Moores K., White J.R., Elshourbagy N., Appelbaum E., Reape R.J., Brawner M., Makwana J., Foley J.J., Schmidt D.B., Imburgia C., McNulty D., Matthews J., O'Donnell K., O'Shannessy D., Scott M., Groot P.H.E., Macphee C. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J Biol Chem. 272:1997;16404-16413.
25. Rollins B.J., Morrison E.D., Stiles C.D. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc Natl Acad Sci USA. 85:1988;3738-3742.
26. Kulmburg P.A., Huber N.E., Scheer B.J., Wrann M., Baumruker T. Immunoglobulin E plus antigen challenge induces a novel intercrine/chemokine in mouse mast cells. J Exp Med. 176:1992;1773-1778.
27. Heinrich J.N., Ryseck R.P., Macdonald-Bravo H., Bravo R. The product of a novel growth factor-activated gene, fic, is a biologically active 'C-C'-type cytokine. Mol Cell Biol. 13:1993;2020-2030.
28. Thirion S., Nys G., Fiten P., Masure S., Van Damme J., Opdenakker G. Mouse macrophage derived monocyte chemotactic protein-3: cDNA cloning and identification as MARC/FIC. Biochem Biophys Res Commun. 201:1994;493-499.
29. Jia G-Q., Gonzalo J.A., Lloyd C., Kremer L., Lu L., Martinez A.C., Wershil B.K., Gutierrez-Ramos J.C. Distinct expression and function of the novel mouse chemokine monocyte chemotactic protein-5 in lung allergic inflammation. J Exp Med. 184:1996;1939-1951.
30. Sarafi M.N., Garcia-Zepeda E.A., MacLean J.A., Charo I.F., Luster A.D. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J Exp Med. 185:1997;99-109.
31. Rothenberg M.E., Luster A.D., Leder P. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA. 92:1995;8960-8964.
32. Opdenakker G., Rudd P.M., Wormald M., Dwek R.A., Van Damme J. Cells regulate the activities of cytokines by glycosylation. FASEB J. 9:1995;453-457.
33. Jiang Y., Valente A.J., Williamson M.J., Zhang L., Graves D.T. Post-translational modification of a monocyte-specific chemoattractant synthesized by glioma, osteosarcoma, and vascular smooth muscle cells. J Biol Chem. 265:1990;18318-18321.
34. Rollins B.J., Stier P., Ernst T., Wong G.G. The human homolog of the JE gene encodes a monocyte secretory protein. Mol Cell Biol. 9:1989;4687-4695.
35. Proost P., Struyf S., Couvreur M., Lenaerts J-P., Conings R., Menten P., Verhaert P., Wuyts A., Van Damme J. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor. J Immunol. 160:1998;4034-4041.
36. Minty A., Chalon P., Guillemot J.C., Kaghad M., Liauzun P., Magazin M., Miloux B., Minty C., Ramond P., Vita N., Lupker J., Shire D., Ferrara P., Caput D. Molecular cloning of the MCP-3 chemokine gene and regulation of its expression. Eur Cytokine Netw. 4:1993;99-110.
37. Noso N., Bartels J., Mallet A.I., Mochizuki M., Christophers E., Schröder J.M. Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-α-stimulated dermal fibroblasts. Eur J Biochem. 253:1998;114-122.
38. Mochizuki M., Bartels J., Mallet A.I., Christophers E., Schröder J-M. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol. 160:1998;60-68.
39. 2-terminal residues. J Exp Med. 181:1995;631-640.
40. Van Coillie E., Proost P., Van Aelst I., Struyf S., Polfliet M., De Meester I., Harvey D.J., Van Damme J., Opdenakker G. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the aminoterminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry. 37:1998;12672-12680.
41. Masure S., Paemen L., Proost P., Van Damme J., Opdenakker G. Expression of a human mutant monocyte chemotactic protein 3 in Pichia pastoris and characterization as an MCP-3 receptor antagonist. J Interferon Cytokine Res. 15:1995;955-963.
42. Proost P., De Meester I., Schols D., Struyf S., Lambeir A-M., Wuyts A., Opdenakker G., De Clercq E., Scharpé S., Van Damme J. Amino-terminal truncation of chemokines by CD26/dipeptidyl peptidase IV (CD26/DPP IV). Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem. 273:1998;7222-7227.
43. Gronenborn A.M., Clore G.M. Modeling the three-dimensional structure of the monocyte chemo-attractant and activating protein MCAF/MCP-1 on the basis of the solution structure of interleukin-8. Protein Eng. 4:1991;263-269.
44. Lodi P.J., Garrett D.S., Kuszewski J., Tsang M.L.S., Weatherbee J.A., Leonard W.J., Gronenborn A.M., Clore G.M. High-resolution solution structure of the β chemokine hMIP-1β by multidimensional NMR. Science. 263:1994;1762-1767.
45. Paolini J.F., Willard D., Consler T., Luther M., Krangel M.S. The chemokines IL-8, monocyte chemoattractant protein-1, and I-309 are monomers at physiologically relevant concentrations. J Immunol. 153:1994;2704-2717.
46. 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer. Biochemistry. 35:1996;6569-6584.
47. Lubkowski J., Bujacz G., Boque L., Domaille P.J., Handel T.M., Wlodawer A. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nat Struct Biol. 4:1997;64-69.
48. Kim K.S., Rajarathnam K., Clark-Lewis I., Sykes B.D. Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. FEBS Lett. 395:1996;277-282.
49. 1H two-dimensional NMR spectroscopy. Biochemistry. 36:1997;4412-4422.
50. Crump M.P., Rajarathnam K., Kim K.S., Clark-Lewis I., Sykes B.D. Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation. J Biol Chem. 273:1998;22471-22479.
51. Furutani Y., Nomura H., Notake M., Oyamada Y., Fukui T., Yamada M., Larsen C.G., Oppenheim J.J., Matsushima K. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem Biophys Res Commun. 159:1989;249-255.
52. Yoshimura T., Yuhki N., Moore S.K., Appella E., Lerman M.I., Leonard E.J. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244:1989;487-493.
53. Cochran B.H., Reffel A.C., Stiles C.D. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell. 33:1983;939-947.
54. Opdenakker G., Fiten P., Nys G., Froyen G., Van Roy N., Speleman F., Laureys G., Van Damme J. The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12. Genomics. 21:1994;403-408.
55. Opdenakker G., Froyen G., Fiten P., Proost P., Van Damme J. Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. Biochem Biophys Res Commun. 191:1993;535-542.
56. Van Coillie E., Fiten P., Nomiyama H., Sakaki Y., Miura R., Yoshie O., Van Damme J., Opdenakker G. The human MCP-2 gene (SCYA8): cloning, sequence analysis, tissue expression, and assignment to the CC chemokine gene contig on chromosome 17q11.2. Genomics. 40:1997;323-331.
57. Van Coillie E., Froyen G., Nomiyama H., Miura R., Fiten P., Van Aelst I., Van Damme J., Opdenakker G. Human monocyte chemotactic protein-2: cDNA cloning and regulated expression of mRNA in mesenchymal cells. Biochem Biophys Res Commun. 231:1997;726-730.
58. Chang H.C., Hsu F., Freeman G.J., Griffin J.D., Reinherz E.L. Cloning and expression of a γ-interferon-inducible gene in monocytes: a new member of a cytokine gene family. Int Immunol. 1:1989;388-397.
59. Rollins B.J., Morton C.C., Ledbetter D.H., Eddy R.L.J., Shows T.B. Assignment of the human small inducible cytokine A2 gene, SCYA2 (encoding JE or MCP-1), to 17q11.2-12: evolutionary relatedness of cytokines clustered at the same locus. Genomics. 10:1991;489-492.
60. Mehrabian M., Sparkes R.S., Mohandas T., Fogelman A.M., Lusis A.J. Localization of monocyte chemotactic protein-1 gene (SCYA2) to human chromosome 17q11.2-q21.1. Genomics. 9:1991;200-203.
61. Laureys G., Speleman F., Versteeg R., van der Drift P., Chan A., Leroy J., Francke U., Opdenakker G., Van Roy N. Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers. Oncogene. 10:1995;1087-1093.
62. Opdenakker G, Van Damme J. Novel monocyte chemoattractants in cancer. In: Rollins B.J., editors. Chemokines and cancer. Harvard University Press, 1999 (in press).
63. Wilson S.D., Billings P.R., D'Eustachio P., Fournier R.E.K., Geissler E., Lalley P.A., Burd P.R., Housman D.E., Taylor B.A., Dorf M.E. Clustering of cytokine genes on mouse chromosome 11. J Exp Med. 171:1990;1301-1314.
64. Li Y-S., Kolattukudy P.E. Functional role of the cis-acting elements in human monocyte chemotactic protein-1 gene in the regulation of its expression by phorbol ester in human glioblastoma cells. Mol Cell Biochem. 141:1994;121-128.
65. Shyy J.Y.J., Lin M-C., Han J., Lu Y., Petrime M., Chien S. The cis-acting phorbol ester '12-O-tetradecanoylphorbol 13-acetate'-responsive element is involved in shear stress-induced monocyte chemotactic protein 1 gene expression. Proc Natl Acad Sci USA. 92:1995;8069-8073.
66. Ueda A., Okuda K., Ohno S., Shirai A., Igarashi T., Matsunaga K., Fukushima J., Kawamoto S., Ishigatsubo Y., Okubo T. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol. 153:1994;2052-2063.
67. Ueda A., Ishigatsubo Y., Okubo T., Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. J Biol Chem. 272:1997;31092-31099.
68. Martin T., Cardarelli P.M., Parry G.C.N., Felts K.A., Cobb R.R. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κB and AP-1. Eur J Immunol. 27:1997;1091-1097.
69. Majumder S., Zhou L.Z-H., Ransohoff R.M. Transcriptional regulation of chemokine gene expression in astrocytes. J Neurosci Res. 45:1996;758-769.
70. Murakami K., Nomiyama H., Miura R., Follens A., Fiten P., Van Coillie E., Van Damme J., Opdenakker G. Structural and functional analysis of the promoter region of the human MCP-3 gene: transactivation of expression by novel recognition sequences adjacent to the transcription initiation site. DNA Cell Biol. 16:1997;173-183.
71. Gao J-L., Kuhns D.B., Tiffany H.L., McDermott D., Li X., Francke U., Murphy P.M. Structure and functional expression of the human macrophage inflammatory protein 1α/RANTES receptor. J Exp Med. 177:1993;1421-1427.
72. Wells T.N.C., Power C.A., Lusti-Narasimhan M., Hoogewerf A.J., Cooke R.M., Chung C., Peitsch M.C., Proudfoot A.E.I. Selectivity and antagonism of chemokine receptors. J Leukoc Biol. 59:1996;53-60.
73. Murphy P.M. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 7:1996;47-64.
74. Loetscher P., Seitz M., Baggiolini M., Moser B. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med. 184:1996;569-577.
75. Sica A., Saccani A., Borsatti A., Power C.A., Wells T.N.C., Luini W., Polentarutti N., Sozzani S., Mantovani A. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med. 185:1997;969-974.
76. Penton-Rol G., Polentarutti N., Luini W., Borsatti A., Mancinelli R., Sica A., Sozzani S., Mantovani A. Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-γ J Immunol. 160:1998;3869-3873.
77. Neote K., DiGregorio D., Mak J.Y., Horuk R., Schall T.J. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell. 72:1993;415-425.
78. Franci C., Wong L.M., Van Damme J., Proost P., Charo I.F. Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor. J Immunol. 154:1995;6511-6517.
79. Combadiere C., Ahuja S.K., Van Damme J., Tiffany H.L., Gao J-L., Murphy P.M. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem. 270:1995;29671-29675.
80. Gong X., Gong W., Kuhns D.B., Ben-Baruch A., Howard O.M.Z., Wang J.M. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J Biol Chem. 272:1997;11682-11685.
81. Charo I.F., Myers S.J., Herman A., Franci C., Connolly A.J., Coughlin S.R. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA. 91:1994;2752-2756.
82. Wong L-M., Myers S.J., Tsou C-L., Gosling J., Arai H., Charo I.F. Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J Biol Chem. 272:1997;1038-1045.
83. Moore U.M., Kaplow J.M., Pleass R.D., Castro S.W., Naik K., Lynch C.N., Daly S., Roach A.G., Jaye M., Williams R.J. Monocyte chemoattractant protein-2 is a potent agonist of CCR2B. J Leukoc Biol. 62:1997;911-915.
84. Yamagami S., Tanaka H., Endo N. Monocyte chemoattractant protein-2 can exert its effects through the MCP-1 receptor (CC CKR2B). FEBS Lett. 400:1997;329-332.
85. Garcia-Zepeda E.A., Combadiere C., Rothenberg M.E., Sarafi M.N., Lavigne F., Hamid Q., Murphy P.M., Luster A.D. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol. 157:1996;5613-5626.
86. Godiska R., Chantry D., Raport C.J., Schweickart V.L., Trong H.L., Gray P.W. Monocyte chemotactic protein-4: tissue-specific expression and signaling through CC chemokine receptor-2. J Leukoc Biol. 61:1997;353-360.
87. Daugherty B.L., Siciliano S.J., DeMartino J.A., Malkowitz L., Sirotina A., Springer M.S. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med. 183:1996;2349-2354.
88. Heath H., Qin S., Rao P., Wu L., LaRosa G., Kassam N., Ponath P.D., Mackay C.R. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest. 99:1997;178-184.
89. Uguccioni M., Mackay C.R., Ochensberger B., Loetscher P., Rhis S., LaRosa G.J., Rao P., Ponath P.D., Baggiolini M., Dahinden C.A. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest. 100:1997;1137-1143.
90. Gerber B.O., Zanni M.P., Uguccioni M., Loetscher M., Mackay C.R., Pichler W.J., Yawalkar N., Baggiolini M., Moser B. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr Biol. 7:1997;836-843.
91. Sallusto F., Mackay C.R., Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 277:1997;2005-2007.
92. Rubbert A., Combadiere C., Ostrowski M., Arthos J., Dybul M., Machado E., Cohn M.A., Hoxie J.A., Murphy P.M., Fauci A.S., Weissman D. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J Immunol. 160:1998;3933-3941.
93. He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., Mackay C.R., Sodroski J., Gabuzda D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 385:1997;645-649.
94. Gong W., Howard O.M.Z., Turpin J.A., Grimm M.C., Ueda H., Gray P.W., Raport C.J., Oppenheim J.J., Wang J.M. Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. J Biol Chem. 273:1998;4289-4292.
95. Doranz B.J., Rucker J., Yi Y., Smyth R.J., Samson M., Peiper S.C., Parmentier M., Collman R.G., Doms R.W. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
96. Sozzani S., Luini W., Borsatti A., Polentarutti N., Zhou D., Piemonti L., D'Amico G., Power C.A., Wells T.N.C., Gobbi M., Allavena P., Mantovani A. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol. 159:1997;1993-2000.
97. Bonini J.A., Martin S.K., Dralyuk F., Roe M.W., Philipson L.H., Steiner D.F. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. DNA Cell Biol. 16:1997;1249-1256.
98. Yoshimura T., Robinson E.A., Tanaka S., Appella E., Kuratsu J-I., Leonard E.J. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med. 169:1989;1449-1459.
99. Cushing S.D., Berliner J.A., Valente A.J., Territo M.C., Navab M., Parhami F., Gerrity R., Schwartz C.J., Fogelman A.M. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 87:1990;5134-5138.
100. Shyy Y-J., Li Y-S., Kolattukudy P.E. Structure of human monocyte chemotactic protein gene and its regulation by TPA. Biochem Biophys Res Commun. 169:1990;346-351.
101. Sica A., Wang J.M., Colotta F., Dejana E., Mantovani A., Oppenheim J.J., Larsen C.G., Zachariae C.O.C., Matsushima K. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol. 144:1990;3034-3038.
102. Rollins B.J., Pober J.S. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am J Pathol. 138:1991;1315-1319.
103. Colotta F., Sciacca F.L., Sironi M., Luini W., Rabiet M.J., Mantovani A. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol. 144:1994;975-985.
104. Shyy Y-J., Hsieh H-J., Usami S., Chien S. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc Natl Acad Sci USA. 91:1994;4678-4682.
105. Larsen C.G., Zachariae C.O.C., Oppenheim J.J., Matsushima K. Production of monocyte chemotactic and activating factor (MCAF) by human dermal fibroblasts in response to interleukin 1 or tumor necrosis factor. Biochem Biophys Res Commun. 160:1989;1403-1408.
106. Van Damme J., Proost P., Put W., Arens S., Lenaerts J-P., Conings R., Opdenakker G., Heremans H., Billiau A. Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J Immunol. 152:1994;5495-5502.
107. Struyf S., Van Coillie E., Paemen L., Put W., Lenaerts J-P., Proost P., Opdenakker G., Van Damme J. Synergistic induction of monocyte chemotactic protein-1 and -2 by interleukin-1β and interferons in fibroblasts and epithelial cells. J Leukoc Biol. 63:1998;364-372.
108. Van Damme J., Decock B., Lenaerts J-P., Conings R., Bertini R., Mantovani A., Billiau A. Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-stranded RNA or cytokine. Eur J Immunol. 19:1989;2367-2373.
109. Yoshimura T., Robinson E.A., Tanaka S., Appella E., Leonard E.J. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J Immunol. 142:1989;1956-1962.
110. Colotta F., Borré A., Wang J.M., Tattanelli M., Maddalena F., Polentarutti N., Peri G., Mantovani A. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol. 148:1992;760-765.
111. Weyrich A.S., McIntyre T.M., McEver R.P., Prescott S.M., Zimmerman G.A. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-α secretion. Signal integration and NF-κB translocation. J Clin Invest. 95:1995;2297-2303.
112. Seitz M., Loetscher P., Dewald B., Towbin H., Gallati H., Baggiolini M. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol. 25:1995;1129-1132.
113. McKee C.M., Penno M.B., Cowman M., Burdick M.D., Strieter R.M., Bao C., Noble P.W. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest. 98:1996;2403-2413.
114. Badolato R., Ponzi A.N., Millesimo M., Notarangelo L.D., Musso T. Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood. 90:1997;2804-2809.
115. Biswas P., Delfanti F., Bernasconi S., Mengozzi M., Cota M., Polentarutti N., Mantovani A., Lazzarin A., Sozzani S., Poli G. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood. 91:1998;258-265.
116. Standiford T.J., Kunkel S.L., Phan S.H., Rollins B.J., Strieter R.M. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem. 266:1991;9912-9918.
117. Schmouder R.L., Strieter R.M., Kunkel S.L. Interferon-γ regulation of human renal cortical epithelial cell-derived monocyte chemotactic peptide-1. Kidney Int. 44:1993;43-49.
118. Barker J.N.W.N., Jones M.L., Swenson C.L., Sarma V., Mitra R.S., Ward P.A., Johnson K.J., Fantone J.C., Dixit V.M., Nickoloff B.J. Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-γ J Immunol. 146:1991;1192-1197.
119. Zachariae C.O.C., Thestrup-Pedersen K., Matsushima K. Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells. J Invest Dermatol. 97:1991;593-599.
120. Wang J.M., Sica A., Peri G., Walter S., Padura I.M., Libby P., Ceska M., Lindley I., Colotta F., Mantovani A. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb. 11:1991;1166-1174.
121. Torzewski J., Oldroyd R., Lachmann P., Fitzsimmons C., Proudfoot D., Bowyer D. Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol. 16:1996;673-677.
122. Marumo T., Schini-Kerth V.B., Fisslthaler B., Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-κB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation. 96:1997;2361-2367.
123. Jonjic N., Peri G., Bernasconi S., Sciacca F.L., Colotta F., Pelicci P., Lanfrancone L., Mantovani A. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med. 176:1992;1165-1174.
124. Brown Z., Strieter R.M., Neild G.H., Thompson R.C., Kunkel S.L., Westwick J. IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells. Kidney Int. 42:1992;95-101.
125. Rovin B.H., Yoshimura T., Tan L. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol. 148:1992;2148-2153.
126. Grandaliano G., Valente A.J., Rozek M.M., Abboud H.E. Gamma interferon stimulates monocyte chemotactic protein (MCP-1) in human mesangial cells. J Lab Clin Med. 123:1994;282-289.
127. Grandaliano G., Valente A.J., Abboud H.E. A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production. J Exp Med. 179:1994;1737-1741.
128. Schwarz M., Radeke H.H., Resch K., Uciechowski P. Lymphocyte-derived cytokines induce sequential expression of monocyte- and T cell-specific chemokines in human mesangial cells. Kidney Int. 52:1997;1521-1531.
129. Villiger P.M., Terkeltaub R., Lotz M. Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest. 90:1992;488-496.
130. Zhu J-F., Valente A.J., Lorenzo J.A., Carnes D., Graves D.T. Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators. J Bone Miner Res. 9:1994;1123-1130.
131. Marra F., Valente A.J., Pinzani M., Abboud H.E. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest. 92:1993;1674-1680.
132. Barna B.P., Pettay J., Barnett G.H., Zhou P., Iwasaki K., Estes M.L. Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor. J Neuroimmunol. 50:1994;101-107.
133. Peterson P.K., Hu S., Salak-Johnson J., Molitor T.W., Chao C.C. Differential production of and migratory response to β chemokines by human microglia and astrocytes. J Infect Dis. 175:1997;478-481.
134. Graves D.T., Jiang Y.L., Williamson M.J., Valente A.J. Identification of monocyte chemotactic activity produced by malignant cells. Science. 245:1989;1490-1493.
135. Matsushima K., Larsen C.G., DuBois G.C., Oppenheim J.J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med. 169:1989;1485-1490.
136. Bottazzi B., Colotta F., Sica A., Nobili N., Mantovani A. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int J Cancer. 45:1990;795-797.
137. Takeya M., Yoshimura T., Leonard E.J., Kato T., Okabe H., Takahashi K. Production of monocyte chemoattractant protein-1 by malignant fibrous histiocytoma: relation to the origin of histiocyte-like cells. Exp Mol Pathol. 54:1991;61-71.
138. Mantovani A., Bottazzi B., Colotta F., Sozzani S., Ruco L. The origin and function of tumor-associated macrophages. Immunol Today. 13:1992;265-270.
139. Brach M.A., Gruss H-J., Riedel D., Asano Y., De Vos S., Herrmann F. Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes. Mol Pharmacol. 42:1992;63-68.
140. Lukacs N.W., Kunkel S.L., Burdick M.D., Strieter R.M. The production of chemotactic cytokines in an allogeneic response. The role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3. Am J Pathol. 143:1993;1179-1188.
141. Liebler J.M., Kunkel S.L., Burdick M.D., Standiford T.J., Rolfe M.W., Strieter R.M. Production of IL-8 and monocyte chemotactic peptide-1 by peripheral blood monocytes. Disparate responses to phytohemagglutinin and lipopolysaccharide. J Immunol. 152:1994;241-249.
142. Zeiher A.M., Fisslthaler B., Schray-Utz B., Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res. 76:1995;980-986.
143. Miyamasu M., Misaki Y., Izumi S., Takaishi T., Morita Y., Nakamura H., Matsushima K., Kasahara T., Hirai K. Glucocorticoids inhibit chemokine generation by human eosinophils. J Allergy Clin Immunol. 101:1998;75-83.
144. Izumi S., Hirai K., Miyamasu M., Takahashi Y., Misaki Y., Takaishi T., Morita Y., Matsushima K., Ida N., Nakamura H., Kasahara T., Ito K. Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils. Eur J Immunol. 27:1997;816-824.
145. Baghestanian M., Hofbauer R., Kiener H.P., Bankl H.C., Wimazal F., Willheim M., Scheiner O., Füreder W., Müller M.R., Bevec D., Lechner K., Valent P. The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells. Blood. 90:1997;4438-4449.
146. McManus C., Berman J.W., Brett F.M., Staunton H., Farrell M., Brosnan C.F. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol. 86:1998;20-29.
147. Polentarutti N., Introna M., Sozzani S., Mancinelli R., Mantovani G., Mantovani A. Expression of monocyte chemotactic protein-3 in human monocytes and endothelial cells. Eur Cytokine Netw. 8:1997;271-274.
148. Menten P, Proost P, Struyf S, Put W, Lenaerts J-P, Conings R, Jaspar J-M, De Groote D, Van Coillie E, Billiau A, Opdenakker G, Van Damme J. Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-α/β and interferon-γ reveals MCP-3 heterogeneity. Eur J Immunol 1999;29:678-685.
149. Vouret-Craviari V., Cenzuales S., Poli G., Mantovani A. Expression of monocyte chemotactic protein-3 in human monocytes exposed to the mycobacterial cell wall component lipoarabinomannan. Cytokine. 9:1997;992-998.
150. Stellato C., Collins P., Ponath P.D., Soler D., Newman W., La Rosa G., Li H., White J., Schwiebert L.M., Bickel C., Liu M., Bochner B.S., Williams T., Schleimer R.P. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest. 99:1997;926-936.
151. Petering H., Höchstetter R., Kimmig D., Smolarski R., Kapp A., Elsner J. Detection of MCP-4 in dermal fibroblasts and its activation of the respiratory burst in human eosinophils. J Immunol. 160:1998;555-558.
152. Bartels J., Schlüter C., Richter E., Noso N., Kulke R., Christophers E., Schröder J-M. Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. Biochem Biophys Res Commun. 225:1996;1045-1051.
153. Hein H., Schlüter C., Kulke R., Christophers E., Schröder J-M., Bartels J. Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem Biophys Res Commun. 237:1997;537-542.
154. Lamkhioued B., Renzi P.M., Abi-Younes S., Garcia-Zepeda E.A., Allakhverdi Z., Ghaffar O., Rothenberg M.D., Luster A.D., Hamid Q. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol. 159:1997;4593-4601.
155. Lilly C.M., Nakamura H., Kesselman H., Nagler-Anderson C., Asano K., Garcia-Zepeda E.A., Rothenberg M.E., Drazen J.M., Luster A.D. Expression of eotaxin by human lung epithelial cells. Induction by cytokines and inhibition by glucocorticoids. J Clin Invest. 99:1997;1767-1773.
156. Mattoli S., Stacey M.A., Sun G., Bellini A., Marini M. Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun. 236:1997;299-301.
157. Minshall E.M., Cameron L., Lavigne F., Leung D.Y.M., Hamilos D., Garcia-Zepeda E.A., Rothenberg M., Luster A.D., Hamid Q. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol. 17:1997;683-690.
158. Ying S., Robinson D.S., Meng Q., Rottman J., Kennedy R., Ringler D.J., Mackay C.R., Daugherty B.L., Springer M.S., Durham S.R., Williams T.J., Kay A.B. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol. 27:1997;3507-3516.
159. Sozzani S., Zhou D., Locati M., Rieppi M., Proost P., Magazin M., Vita N., Van Damme J., Mantovani A. Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1. J Immunol. 152:1994;3615-3622.
160. Uguccioni M., D'Apuzzo M., Loetscher M., Dewald B., Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur J Immunol. 25:1995;64-68.
161. + T lymphocytes. FASEB J. 8:1994;1055-1060.
162. Taub D.D., Proost P., Murphy W.J., Anver M., Longo D.L., Van Damme J., Oppenheim J.J. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest. 95:1995;1370-1376.
163. Dahinden C.A., Geiser T., Brunner T., von Tscharner V., Caput D., Ferrara P., Minty A., Baggiolini M. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med. 179:1994;751-756.
164. Noso N., Proost P., Van Damme J., Schröder J.M. Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem Biophys Res Commun. 200:1994;1470-1476.
165. Weber M., Uguccioni M., Ochensberger B., Baggiolini M., Clark-Lewis I., Dahinden C.A. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol. 154:1995;4166-4172.
166. Alam R., Forsythe P., Stafford S., Heinrich J., Bravo R., Proost P., Van Damme J. Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils. J Immunol. 153:1994;3155-3159.
167. Allavena P., Bianchi G., Zhou D., Van Damme J., Jílek P., Sozzani S., Mantovani A. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol. 24:1994;3233-3236.
168. 2+ mobilization, and enzyme release. J Immunol. 156:1996;322-327.
169. Sozzani S., Sallusto F., Luini W., Zhou D., Piemonti L., Allavena P., Van Damme J., Valitutti S., Lanzavecchia A., Mantovani A. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol. 155:1995;3292-3295.
170. Xu L.L., Warren M.K., Rose W.L., Gong W., Wang J.M. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J Leukoc Biol. 60:1996;365-371.
171. Xu L.L., McVicar D.W., Ben-Baruch A., Kuhns D.B., Johnston J., Oppenheim J.J., Wang J.M. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur J Immunol. 25:1995;2612-2617.
172. Taub D.D., Sayers T.J., Carter C.R.D., Ortaldo J.R. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol. 155:1995;3877-3888.
173. Elsner J., Höchstetter R., Kimmig D., Kapp A. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol. 26:1996;1919-1925.
174. Tenscher K., Metzner B., Hofmann C., Schopf E., Norgauer J. The monocyte chemotactic protein-4 induces oxygen radical production, actin reorganization, and CD11b up-regulation via a pertussis toxin-sensitive G-protein in human eosinophils. Biochem Biophys Res Commun. 240:1997;32-35.
175. Jiang Y., Beller D.I., Frendl G., Graves D.T. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol. 148:1992;2423-2428.
176. Vaddi K., Newton R.C. Regulation of monocyte integrin expression by β-family chemokines. J Immunol. 153:1994;4721-4732.
177. Yamada H., Hirai K., Miyamasu M., Iikura M., Misaki Y., Shoji S., Takaishi T., Kasahara T., Morita Y., Ito K. Eotaxin is a potent chemotaxin for human basophils. Biochem Biophys Res Commun. 231:1997;365-368.
178. Rutledge B.J., Rayburn H., Rosenberg R., North R.J., Gladue R.P., Corless C.L., Rollins B.J. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol. 155:1995;4838-4843.
179. Fuentes M.E., Durham S.K., Swerdel M.R., Lewin A.C., Barton D.S., Megill J.R., Bravo R., Lira S.A. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol. 155:1995;5769-5776.
180. Grewal I.S., Rutledge B.J., Fiorillo J.A., Gu L., Gladue R.P., Flavell R.A., Rollins B.J. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J Immunol. 159:1997;401-408.
181. Gunn M.D., Nelken N.A., Liao X., Williams L.T. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol. 158:1997;376-383.
182. Nakamura K., Williams I.R., Kupper T.S. Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J Invest Dermatol. 105:1995;635-643.
183. Kolattukudy P.E., Quach T., Bergese S., Breckenridge S., Hensley J., Altschuld R., Gordillo G., Klenotic S., Orosz C., Parker-Thornburg J. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am J Pathol. 152:1998;101-111.
184. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med. 187:1998;601-608.
185. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 2:1998;275-281.
186. Matthews A.N., Friend D.S., Zimmermann N., Sarafi M.N., Luster A.D., Pearlman E., Wert S.E., Rothenberg M.E. Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci USA. 95:1998;6273-6278.
187. Rothenberg M.E., MacLean J.A., Pearlman E., Luster A.D., Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med. 185:1997;785-790.
188. Gao J-L., Wynn T.A., Chang Y., Lee E.J., Broxmeyer H.E., Cooper S., Tiffany H.L., Westphal H., Kwon-Chung J., Murphy P.M. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med. 185:1997;1959-1968.
189. Gerard C., Frossard J-L., Bhatia M., Saluja A., Gerard N.P., Lu B., Steer M. Targeted disruption of the β-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest. 100:1997;2022-2027.
190. Kurihara T., Warr G., Loy J., Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med. 186:1997;1757-1762.
191. Boring L., Gosling J., Chensue S.W., Kunkel S.L., Farese R.V., Broxmeyer H.E., Charo I.F. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest. 100:1997;2552-2561.
192. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2(-/-) mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897.
193. Gillitzer R., Wolff K., Tong D., Müller C., Yoshimura T., Hartmann A.A., Stingl G., Berger R. MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol. 101:1993;127-131.
194. Yu X., Barnhill R.L., Graves D.T. Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin. Lab Invest. 71:1994;226-235.
195. Koch A.E., Kunkel S.L., Harlow L.A., Johnson B., Evanoff H.L., Haines G.K., Burdick M.D., Pope R.M., Strieter R.M. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest. 90:1992;772-779.
196. Harigai M., Hara M., Yoshimura T., Leonard E.J., Inoue K., Kashiwazaki S. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol. 69:1993;83-91.
197. Antoniades H.N., Neville-Golden J., Galanopoulos T., Kradin R.L., Valente A.J., Graves D.T. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA. 89:1992;5371-5375.
198. Sousa A.R., Lane S.J., Nakhosteen J.A., Yoshimura T., Lee T.H., Poston R.N. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol. 10:1994;142-147.
199. Ying S., Taborda-Barata L., Meng Q., Humbert M., Kay A.B. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med. 181:1995;2153-2159.
200. Kuna P., Lazarovich M., Kaplan A.P. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol. 97:1996;104-112.
201. Luster A.D., Rothenberg M.E. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J Leukoc Biol. 62:1997;620-633.
202. Kurashima K., Mukaida N., Fujimura M., Yasui M., Nakazumi Y., Matsuda T., Matsushima K. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med. 155:1997;1474-1477.
203. + T cells during a pulmonary Cryptococcus neoformans infection. J Immunol. 155:1995;4790-4797.
204. Ylä-Herttuala S., Lipton B.A., Rosenfeld M.E., Särkioja T., Yoshimura T., Leonard E.J., Witztum J.L., Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA. 88:1991;5252-5256.
205. Pervin S., Singh R., Rosenfeld M.E., Navab M., Chaudhuri G., Nathan L. Estradiol suppresses MCP-1 expression in vivo - Implications for atherosclerosis. Arterioscler Thromb Vasc Biol. 18:1998;1575-1582.
206. Aukrust P., Ueland T., Müller F., Andreassen A.K., Nordoy I., Aas H., Kjekshus J., Simonsen S., Froland S.S., Gullestad L. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation. 97:1998;1136-1143.
207. Bossink A.W.J., Paemen L., Jansen P.M., Hack C.E., Thijs L.G., Van Damme J. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood. 86:1995;3841-3847.
208. Reinecker H-C., Loh E.Y., Ringler D.J., Mehta A., Rombeau J.L., MacDermott R.P. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology. 108:1995;40-50.
209. Czaja M.J., Geerts A., Xu J., Schmiedeberg P., Ju Y. Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol. 55:1994;120-126.
210. Spanaus K-S., Nadal D., Pfister H-W., Seebach J., Widmer U., Frei K., Gloor S., Fontana A. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J Immunol. 158:1997;1956-1964.
211. Lahrtz F., Piali L., Nadal D., Pfister H-W., Spanaus K-S., Baggiolini M., Fontana A. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-γ inducible protein-10 and monocyte chemotactic protein-1. Eur J Immunol. 27:1997;2484-2489.
212. Fiten P, Vandenbroeck K, Dubois B, Van Coillie E, Nelissen I, Van Damme J, Ligers A, Hillert J, Anderson M, Olsson T, Opdenakker G. Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 (MCP-3) and analysis of the association between MCP-3 alleles and MS development. J Neuroimmunol 1999 (in press).
213. Rovin B.H., Rumancik M., Tan L., Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest. 71:1994;536-542.
214. Prodjosudjadi W., Gerritsma J.S.J., Klar-Mohamad N., Gerritsen A.F., Bruijn J.A., Daha M.R., van Es L.A. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int. 48:1995;1477-1486.
215. Noris M., Bernasconi S., Casiraghi F., Sozzani S., Gotti E., Remuzzi G., Mantovani A. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest. 73:1995;804-809.
216. Marsh C.B., Wewers M.D., Tan L.C., Rovin B.H. Fcγ receptor cross-linking induces peripheral blood mononuclear cell monocyte chemoattractant protein-1 expression. Role of lymphocyte FcγRIII. J Immunol. 158:1997;1078-1084.
217. Akoum A., Lemay A., McColl S., Turcot-Lemay L., Maheux R. Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis. Fertil Steril. 66:1996;17-23.
218. Graves D.T., Barnhill R., Galanopoulos T., Antoniades H.N. Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol. 140:1992;9-14.
219. Kuratsu Ji, Yoshizato K., Yoshimura T., Leonard E.J., Takeshima H., Ushio Y. Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. J Natl Cancer Inst. 85:1993;1836-1839.
220. Sciacca F.L., Stürzl M., Bussolino F., Sironi M., Brandstetter H., Zietz C., Zhou D., Matteucci C., Peri G., Sozzani S., Benelli R., Arese M., Albini A., Colotta F., Mantovani A. Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J Immunol. 153:1994;4816-4825.
221. Takeshima H., Kuratsu J-I., Takeya M., Yoshimura T., Ushio Y. Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J Neurosurg. 80:1994;1056-1062.
222. Negus R.P.M., Stamp G.W.H., Relf M.G., Burke F., Malik S.T.A., Bernasconi S., Allavena P., Sozzani S., Mantovani A., Balkwill F.R. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest. 95:1995;2391-2396.
223. Amann B., Perabo F.G.E., Wirger A., Hugenschmidt H., Schultze-Seemann W. Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer. Br J Urol. 82:1998;118-121.
224. Rollins B.J., Sunday M.E. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol Cell Biol. 11:1991;3125-3131.
225. Fioretti F., Fradelizi D., Stoppacciaro A., Ramponi S., Ruco L., Minty A., Sozzani S., Garlanda C., Vecchi A., Mantovani A. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. J Immunol. 161:1998;342-346.
226. Decock B., Conings R., Lenaerts J-P., Billiau A., Van Damme J. Identification of the monocyte chemotactic protein from human osteosarcoma cells and monocytes: detection of a novel N-terminally processed form. Biochem Biophys Res Commun. 167:1990;904-909.
227. Desbaillets I., Tada M., de Tribolet N., Diserens A-C., Hamou M-F., Van Meir E.G. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer. 58:1994;240-247.
228. Sozzani S., Luini W., Molino M., Jilek P., Bottazzi B., Cerletti C., Matsushima K., Mantovani A. The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. J Immunol. 147:1991;2215-2221.
229. Proost P., Van Leuven P., Wuyts A., Ebberink R., Opdenakker G., Van Damme J. Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines. Cytokine. 7:1995;97-104.
230. Sozzani S., Rieppi M., Locati M., Zhou D., Bussolino F., Proost P., Van Damme J., Mantovani A. Synergism between platelet activating factor and C-C chemokines for arachidonate release in human monocytes. Biochem Biophys Res Commun. 199:1994;761-766.
231. Rollins B.J., Walz A., Baggiolini M. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood. 78:1991;1112-1116.
232. Schols D., Proost P., Van Damme J., De Clercq E. RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE). J Virol. 71:1997;7300-7304.
233. Peled A., Gonzalo J.A., Lloyd C., Gutierrez-Ramos J.C. The chemotactic cytokine eotaxin acts as a granulocyte-macrophage colony-stimulating factor during lung inflammation. Blood. 91:1998;1909-1916.
234. Hohki G., Terada N., Hamano N., Kitaura M., Nakajima T., Yoshie O., Ikeda T., Kimura S., Konno A. The effects of eotaxin on the surface adhesion molecules of endothelial cells and on eosinophil adhesion to microvascular endothelial cells. Biochem Biophys Res Commun. 241:1997;136-141.
235. Jahnz-Rózyk K.M., Kuna P., Pirozynska E. Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis. J Investig Allergol Clin Immunol. 7:1997;254-259.
236. Matsumori A., Furukawa Y., Hashimoto T., Yoshida A., Ono K., Shioi T., Okada M., Iwasaki A., Nishio R., Matsushima K., Sasayama S. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol. 29:1997;419-423.
237. Wong M., Silverman E.D., Fish E.N. Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1β expression in Kawasaki disease. J Rheumatol. 24:1997;1179-1185.
238. Bernasconi S., Cinque P., Peri G., Sozzani S., Crociati A., Torri W., Vicenzi E., Vago L., Lazzarin A., Poli G., Mantovani A. Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J Infect Dis. 174:1996;1098-1101.
239. Cinque P., Vago L., Mengozzi M., Torri V., Ceresa D., Vicenzi E., Transidico P., Vagani A., Sozzani S., Mantovani A., Lazzarin A., Poli G. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS. 12:1998;1327-1332.
240. Marra F., DeFranco R., Grappone C., Milani S., Pastacaldi S., Pinzani M., Romanelli R.G., Laffi G., Gentilini P. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis. Correlation with monocyte infiltration. Am J Pathol. 152:1998;423-430.
241. Grandaliano G., Gesualdo L., Ranieri E., Monno R., Stallone G., Schena F.P. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation. 63:1997;414-420.
242. Conant K., Garzino-Demo A., Nath A., McArthur J.C., Halliday W., Power C., Gallo R.C., Major E.O. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA. 95:1998;3117-3121.
243. Weiss L., Si-Mohamed A., Giral P., Castiel P., Ledur A., Blondin C., Kazatchkine M.D., Haeffner-Cavaillon N. Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1α and RANTES correlate with virus load in human immunodeficiency virus infection. J Infect Dis. 176:1997;1621-1624.
244. Hanazawa S., Kawata Y., Takeshita A., Kumada H., Okithu M., Tanaka S., Yamamoto Y., Masuda T., Umemoto T., Kitano S. Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun. 61:1993;5219-5224.
245. Hashimoto S., Nakayama T., Gon Y., Hata N., Koura T., Maruoka S., Matsumoto K., Hayashi S., Abe Y., Horie T. Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1α (MIP-1α) levels with disease activity and clinical course of sarcoidosis. Clin Exp Immunol. 111:1998;604-610.